159 related articles for article (PubMed ID: 38020313)
1. Impact of Fc receptors and host characteristics on myeloid phagocytic response to rituximab-treated 3D-cultured B-cell lymphoma.
Kleinau S
Immunother Adv; 2023; 3(1):ltad025. PubMed ID: 38020313
[TBL] [Abstract][Full Text] [Related]
2. Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma.
Lara S; Heilig J; Virtanen A; Kleinau S
BMC Cancer; 2022 Jun; 22(1):678. PubMed ID: 35725455
[TBL] [Abstract][Full Text] [Related]
3. Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.
Hatjiharissi E; Hansen M; Santos DD; Xu L; Leleu X; Dimmock EW; Ho AW; Hunter ZR; Branagan AR; Patterson CJ; Kortsaris A; Verselis S; Fox E; Treon SP
Clin Lymphoma Myeloma; 2007 Jan; 7(4):286-90. PubMed ID: 17324336
[TBL] [Abstract][Full Text] [Related]
4. Importance of antibody isotypes in antitumor immunity by monocytes and complement using human-immune tumor models.
Lara S; Anania JC; Virtanen A; Stenhammar V; Kleinau S
Eur J Immunol; 2021 May; 51(5):1218-1233. PubMed ID: 33533020
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of the interchain disulfide bonds in rituximab increases its affinity for FcγRIIIA.
Suzuki M; Yamanoi A; Machino Y; Kobayashi E; Fukuchi K; Tsukimoto M; Kojima S; Kohroki J; Akimoto K; Masuho Y
Biochem Biophys Res Commun; 2013 Jul; 436(3):519-24. PubMed ID: 23764395
[TBL] [Abstract][Full Text] [Related]
7. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
Front Immunol; 2019; 10():704. PubMed ID: 31031746
[TBL] [Abstract][Full Text] [Related]
8. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
[TBL] [Abstract][Full Text] [Related]
9. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
[TBL] [Abstract][Full Text] [Related]
10. An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa
Kang TH; Lee CH; Delidakis G; Jung J; Richard-Le Goff O; Lee J; Kim JE; Charab W; Bruhns P; Georgiou G
Front Immunol; 2019; 10():562. PubMed ID: 30984171
[TBL] [Abstract][Full Text] [Related]
11. Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20
Granot N; Rezvani AR; Pender BS; Storer BE; Sandmaier BM; Storb R; Maloney DG
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1811-1818. PubMed ID: 32693210
[TBL] [Abstract][Full Text] [Related]
12. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.
Isoda Y; Yagi H; Satoh T; Shibata-Koyama M; Masuda K; Satoh M; Kato K; Iida S
PLoS One; 2015; 10(10):e0140120. PubMed ID: 26444434
[TBL] [Abstract][Full Text] [Related]
13. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
[TBL] [Abstract][Full Text] [Related]
14. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.
Beum PV; Lindorfer MA; Taylor RP
J Immunol; 2008 Aug; 181(4):2916-24. PubMed ID: 18684983
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
[TBL] [Abstract][Full Text] [Related]
16. Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy.
Cornec D; Tempescul A; Querellou S; Hutin P; Pers JO; Jamin C; Bendaoud B; Berthou C; Renaudineau Y; Youinou P
Ann Hematol; 2012 May; 91(5):715-721. PubMed ID: 22083514
[TBL] [Abstract][Full Text] [Related]
17. The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases.
Huang ZY; Hunter S; Kim MK; Chien P; Worth RG; Indik ZK; Schreiber AD
J Leukoc Biol; 2004 Aug; 76(2):491-9. PubMed ID: 15136586
[TBL] [Abstract][Full Text] [Related]
18. Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for FcγRI in the pathogenesis of synovial inflammation.
Kempers AC; Nejadnik MR; Rombouts Y; Ioan-Facsinay A; van Oosterhout M; Jiskoot W; Huizinga TWJ; Toes REM; Scherer HU
Clin Exp Rheumatol; 2018; 36(2):284-293. PubMed ID: 29352854
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of human monocytes and NK cells by antibody-opsonized tumors.
Yin J; Albers AJ; Smith TS; Riddell GT; Richards JO
Cancer Immunol Immunother; 2018 Aug; 67(8):1239-1250. PubMed ID: 29855696
[TBL] [Abstract][Full Text] [Related]
20. Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells.
Goh YS; Grant AJ; Restif O; McKinley TJ; Armour KL; Clark MR; Mastroeni P
Immunology; 2011 May; 133(1):74-83. PubMed ID: 21323662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]